Literature DB >> 8869347

18F-fluorodeoxyglucose PET scans in lung cancer.

J M Hughes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8869347      PMCID： PMC1090701          DOI： 10.1136/thx.51.suppl_2.s16

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  32 in total

1.  Detecting recurrent or residual lung cancer with FDG-PET.

Authors:  T Inoue; E E Kim; R Komaki; F C Wong; P Bassa; W H Wong; D J Yang; K Endo; D A Podoloff
Journal:  J Nucl Med       Date:  1995-05       Impact factor: 10.057

2.  Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer.

Authors:  P Lewis; S Griffin; P Marsden; T Gee; T Nunan; M Malsey; J Dussek
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321

3.  Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.

Authors:  N A Dewan; N C Gupta; L S Redepenning; J J Phalen; M P Frick
Journal:  Chest       Date:  1993-10       Impact factor: 9.410

4.  Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.

Authors:  E F Patz; V J Lowe; J M Hoffman; S S Paine; L K Harris; P C Goodman
Journal:  Radiology       Date:  1994-05       Impact factor: 11.105

Review 5.  Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group.

Authors:  W J Scott; J L Schwabe; N C Gupta; N A Dewan; S D Reeb; J T Sugimoto
Journal:  Ann Thorac Surg       Date:  1994-09       Impact factor: 4.330

6.  Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).

Authors:  F G Duhaylongsod; V J Lowe; E F Patz; A L Vaughn; R E Coleman; W G Wolfe
Journal:  J Thorac Cardiovasc Surg       Date:  1995-07       Impact factor: 5.209

7.  PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis.

Authors:  N A Dewan; S D Reeb; N C Gupta; L S Gobar; W J Scott
Journal:  Chest       Date:  1995-08       Impact factor: 9.410

8.  Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.

Authors:  A Frank; D Lefkowitz; S Jaeger; L Gobar; J Sunderland; N Gupta; W Scott; J Mailliard; H Lynch; J Bishop
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-30       Impact factor: 7.038

9.  Characterization of chest masses by FDG positron emission tomography.

Authors:  K F Hübner; E Buonocore; S K Singh; H R Gould; D W Cotten
Journal:  Clin Nucl Med       Date:  1995-04       Impact factor: 7.794

10.  Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography.

Authors:  L H Brudin; S O Valind; C G Rhodes; C F Pantin; M Sweatman; T Jones; J M Hughes
Journal:  Eur J Nucl Med       Date:  1994-04
View more
  4 in total

1.  [Efficacy of F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scans in diagnosis of pulmonary nodules].

Authors:  K Orino; M Kawamura; J Hatazawa; I Suzuki; Y Sazawa
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-12

2.  Transthoracic needle aspiration biopsy for the diagnosis of localised pulmonary lesions: a meta-analysis.

Authors:  Y Lacasse; E Wong; G H Guyatt; D J Cook
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

3.  [Brain metastases of lung cancer: diagnostic accuracy of positron emission tomography with fluorodeoxyglucose (FDG-PET)].

Authors:  I Palm; D Hellwig; M Leutz; K Rentz; A Hellwig; C M Kirsch; D Ukena; G W Sybrecht
Journal:  Med Klin (Munich)       Date:  1999-04-15

4.  Unusual positron emission tomography findings in pulmonary amyloidosis: a case report.

Authors:  Sumit Yadav; Sanjay Sharma; Ian Gilfillan
Journal:  J Cardiothorac Surg       Date:  2006-10-05       Impact factor: 1.637
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.